 | • レポートコード：C-MOR-100280 • 出版社/出版日：Mordor Intelligence / 2019年9月 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療機器 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Multi User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site License | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ラベルフリー検出（LFD）の世界市場について調査・分析し、ラベルフリー検出（LFD）の世界市場規模、市場動向、市場環境分析、市場展望、セグメント別分析、地域別分析、関連企業情報など以下の構成でお届け致します。 |
Market Overview
A label is any foreign molecule that is temporarily attached to the molecule of interest to detect molecular activity and presence. On the other hand, label-free detection methods utilize the biophysical properties of the molecule such as molecular weight and refractive index to monitor molecular presence and activity. The main advantage in LFD techniques is that more direct information can be acquired as the method uses only native proteins and ligands. Innovations in LFD techniques include modification of mass spectrometry to develop surface-enhanced laser desorption/ionization (SELDI) time of flight (TOF)- mass spectrometry (MS) which is an innovative approach that offers on-chip purification of the proteins of interest and subsequent ionization of the retained molecules to be detected. Other innovations in LFD techniques include the modification of surface plasmon resonance (SPR) to develop Localized Surface Plasmon Resonance (LSPR) which provides advantages like lower fabrication costs and higher sensitivity. So, with the introduction of new innovations in the label-free detection technologies the market is expected to experience moderate growth.
Scope of the Report
As per the scope of the report, Label-Free Detection (LFD)s is a method for detecting biomolecules and their interactions. The LFD method has made tremendous advancements due to the combination of knowledge in material sciences, computational design, and nanofabrication.
Key Market Trends
Surface Plasmon Resonance (SPR) is Expected to Hold Largest Share of Global Label-Free Detection (LFD) Market
Based on technology used, surface plasmon resonance (SPR) technology segment the largest share in the global label-free detection market due to its wide application range and compatibility with a wide range of biomolecules. However, the bio-layer interferometry segment is expected to grow at the fastest rate over the forecast period. Interferometry provides advantages like less fluctuation in the refractive index of the samples being tested and microfluidic-free nature of bio-layer interferometry label-free detection systems.
North America Region Holds the Largest Market Share of Label-Free Detection (LFD) Market
North America dominates the global label free detection market due to technological advancement and high government funding in the region. Also, increasing prevalence of disease and the growth in drug discovery programs in the region. Partnerships between pharmaceutical companies and academic institutes and the presence of several pharmaceutical and biotechnological companies will also augment the growth of the market.
Competitive Landscape
The Label-Free Detection (LFD) Market market consists of several major players. The companies are implementing certain strategic initiatives such as merger, new product launch, acquisition and partnerships that help them in strengthening their market position. Further, these leaders have products for all the end users, a strong grographical presence and also focusing on product innovations.
Reasons to Purchase this report:
The market estimate (ME) sheet in Excel format
Report customization as per the client’s requirements
3 months of analyst support
Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing R&D Activities Through Research Partnerships Between Pharmaceutical Companies and Academic Institutes
4.2.2 Innovations in Label-free Detection Technologies
4.3 Market Restraints
4.3.1 High Cost of Instruments
4.3.2 Issues in Sensitivty and Throughput
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Consumables
5.1.1.1 Biosensor Chips
5.1.1.2 Microplates
5.1.2 Instruments
5.2 By Technology
5.2.1 Mass Spectrometry
5.2.2 Surface Plasmon Resonance (SPR)
5.2.3 Bio-Layer Interferometry
5.2.4 Isothermal Titration Calorimetry
5.2.5 Differential Scanning Calorimetry
5.2.6 Other Lfd Technologies
5.3 By Application
5.3.1 Binding Kinetics
5.3.2 Binding Thermodynamics
5.3.3 Endogenous Receptor Detection
5.3.4 Hit Confirmation
5.3.5 Lead Generation
5.3.6 Other Applications
5.4 By End-User
5.4.1 Pharmaceutical & Biotechnology Companies
5.4.2 Academic & Research Institutes
5.4.3 Contract Research Organizations
5.5 Geography
5.5.1 North America
5.5.1.1 US
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 UK
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle East and Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East and Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Ametek Inc.
6.1.2 Corning Incorporated
6.1.3 Danaher Corporation
6.1.4 General Electric Company
6.1.5 Horiba Ltd.
6.1.6 Malvern Panalytical
6.1.7 PerkinElmer Inc.
6.1.8 Shimadzu Corporation
6.1.9 Thermo Fisher Scientific
6.1.10 Fluidic Analytics
7 MARKET OPPORTUNITIES AND FUTURE TRENDS